Showing results (121-130 of 163) with videos related to
Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|February 28, 2001
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemiaR Bellott, A Auvrignon, T Leblanc, et al.Cancer Causes & Control : CCC|January 26, 2002
Family cancer history and risk of childhood acute leukemia (France)F Perrillat, J Clavel, I Jaussent, et al.British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.British Journal of Haematology|November 1, 1996
Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemiaJ Landman-Parker, J Aubin, E Delabesse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.European Journal of Pediatrics|August 23, 2017
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed childrenS Bichali, D Brault, C Masserot, et al.Blood|November 10, 1998
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric OncologyL Brugières, M C Deley, H Pacquement, et al.Journal of Pediatric Hematology/Oncology|July 1, 1997
Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell DiseaseM de Montalembert, M Belloy, F Bernaudin, et al.British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.Pageof 17